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Tenascin-C Aggravates Autoimmune Myocarditis via Dendritic Cell
Activation and Th17 Cell Differentiation
TomokoMachino-Ohtsuka, MD; Kazuko Tajiri, MD, PhD; Taizo Kimura, MD, PhD; Satoshi Sakai, MD, PhD; Akira Sato, MD; Toshimichi Yoshida,
MD, PhD; Michiaki Hiroe, MD, PhD; Yasuhiro Yasutomi, DVM, PhD; Kazutaka Aonuma, MD, PhD; Kyoko Imanaka-Yoshida, MD, PhD
Background-—Tenascin-C (TN-C), an extracellular matrix glycoprotein, appears at several important steps of cardiac development
in the embryo, but is sparse in the normal adult heart. TN-C re-expresses under pathological conditions including myocarditis, and
is closely associated with tissue injury and inﬂammation in both experimental and clinical settings. However, the
pathophysiological role of TN-C in the development of myocarditis is not clear. We examined how TN-C affects the initiation of
experimental autoimmune myocarditis, immunologically.
Methods and Results-—A model of experimental autoimmune myocarditis was established in BALB/c mice by immunization with
murine a-myosin heavy chains. We found that TN-C knockout mice were protected from severe myocarditis compared to wild-type
mice. TN-C induced synthesis of proinﬂammatory cytokines, including interleukin (IL)-6, in dendritic cells via activation of a Toll-like
receptor 4, which led to T-helper (Th)17 cell differentiation and exacerbated the myocardial inﬂammation. In the transfer
experiment, dendritic cells loaded with cardiac myosin peptide acquired the functional capacity to induce myocarditis when
stimulated with TN-C; however, TN-C-stimulated dendritic cells generated from Toll-like receptor 4 knockout mice did not induce
myocarditis in recipients.
Conclusions-—Our results demonstrated that TN-C aggravates autoimmune myocarditis by driving the dendritic cell activation and
Th17 differentiation via Toll-like receptor 4. The blockade of Toll-like receptor 4-mediated signaling to inhibit the proinﬂammatory
effects of TN-C could be a promising therapeutic strategy against autoimmune myocarditis. ( J Am Heart Assoc. 2014;3:e001052
doi: 10.1161/JAHA.114.001052)
Key Words: dendritic cell • myocarditis • tenascin-C • Th17 • TLR4
M yocarditis is induced by a variety of agents,including toxins, alcohols, parasites, bacteria, and
viruses.1,2 Postinfectious autoimmune myocarditis often
results in idiopathic dilated cardiomyopathy (DCM), which
is sometimes a lethal disorder characterized by left
ventricular (LV) enlargement and systolic dysfunction.1,2
Experimental autoimmune myocarditis (EAM) is a mouse
model of such a kind of inﬂammation-based cardiomyopa-
thy.3,4 EAM is known as a CD4+ T-cell-mediated disease,
and activation of self-antigen-loaded dendritic cells (DCs) is
critical for the expansion of autoreactive CD4+ T cells.5
Upon encountering immunologic danger, the maturated and
activated DCs act as an important commander regulating
na€ıve CD4+ T cells by means of antigen presentation,
costimulatory molecule engagement, and release of a
cocktail of polarizing cytokines.6 DC activation is mediated
by the recognition of pathogen-associated molecular pat-
terns and damage-associated molecular patterns, which are
sensed by pattern-recognized receptors such as Toll-like
receptors (TLRs).6
Recently, accumulating evidence has highlighted the
proinﬂammatory role of several extracellular matrix mole-
cules including tenascin-C (TN-C), osteopontin, and galec-
tin.7–10 Of these, TN-C acts as a damage-associated
molecular pattern and directly activates inﬂammatory cells
including lymphocytes, macrophages, synovial ﬁbroblasts,
and DCs.11–14 TN-C is synthesized by various cell types
in response to inﬂammatory cytokines and mechanical
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stress.12,15,16 TN-C is not normally expressed in the adult
heart but is speciﬁcally upregulated during clinical conditions
accompanying inﬂammation,7,17 such as acute myocardial
infarction,18 hypertensive cardiac ﬁbrosis,19 myocarditis,15,20
and some cases of DCM.21 In particular, our previous
analysis of the myocardium obtained from left ventriculopl-
asty specimens of patients with DCM showed that about half
of the patients had signiﬁcant active inﬂammation associated
with TN-C expression.21 Thus, it has been recognized that
TN-C is closely associated with inﬂammatory status in
cardiovascular diseases. However, how TN-C acts as a
proinﬂammatory stimulus by mediating the immune system
in myocarditis has not been fully understood.
Here, we show that TN-C leads to TLR4-mediated inﬂam-
matory responses in DCs and exacerbates myocardial
inﬂammation. TN-C knockout (TNKO) mice were protected
from severe myocarditis in a model of cardiac myosin-induced
autoimmune myocarditis. Furthermore, we found that TN-C
induced synthesis of proinﬂammatory cytokines, including
interleukin-6 (IL-6), in DCs via activation of TLR4, which led to
Th17 cell differentiation. Finally, in the transfer experiment,
DCs loaded with cardiac myosin peptide acquired the
functional capacity to induce myocarditis when stimulated
with TN-C; however, TN-C-stimulated DCs generated from
TLR4 knockout (TLR4KO) mice did not induce myocarditis in
recipients.
Materials and Methods
Mice
TNKO mice, originally generated by Saga et al., were back-
crossed with BALB/c mice for more than 12 generations.22
Male TNKO mice and wild-type (WT) littermates (5 to 7 weeks
of age) were used in the experiments. Other male BALB/c
mice (same age) that were used to obtain bone marrow cells
were purchased from CLEA Japan. TLR4KO mice were
purchased from Oriental Yeast. All animal experiments were
approved by the Institutional Animal Experiment Committee of
the University of Tsukuba.
Induction of EAM
The mice were immunized with 100 lg of a-myosin H-chain
peptide (MyHC-a) (MyHC-a614–629 [Ac-RSLKLMATLFSTYA-
SADR-OH]; Toray Research Center) emulsiﬁed 1:1 in a PBS/
complete Freund’s adjuvant (1 mg/mL; H37Ra; Sigma-
Aldrich) on days 0 and 7, as described previously.23 At
different time points (0, 2, 5, 8, 11, 14, 17, 21, 25, 29, and
33 days) after the ﬁrst immunization, a total of 44 mice were
anesthetized with pentobarbital (60 mg/kg i.p.) and their
hearts were removed.
Myosin-Speciﬁc Bone Marrow-Derived Dendritic
Cell (BMDC)-Induced Myocarditis
BMDCs were generated as previously described.24 BMDCs
were pulsed overnight with 10 lg/mL MyHC-a peptide and
stimulated for another 4 hours with 1 lg/mL lipopolysac-
charide (LPS) (Sigma-Aldrich) or 10 lg/mL TN-C and 5 lg/
mL anti-CD40L (AbD Serotec).5 Recipient mice received
59105 pulsed and activated BMDCs i.p. on days 0, 2, and 4
and were killed 10 days after the ﬁrst injection.
Histopathological and Immunohistochemical
Examination
The hearts were ﬁxed in 4% paraformaldehyde in PBS and
embedded in parafﬁn wax. For a histological analysis, 3-lm-
thick sections were cut and stained with hematoxylin and
eosin. To evaluate the expression of TN-C, we performed
immunohistochemistry as previously described.25 In brief,
sections after antigen retrieval were incubated with poly-
clonal rabbit anti-TN-C antibodies,15,26 followed by treatment
with horseradish peroxidase–conjugated goat anti-rabbit
antibody (MBL, Nagoya, Japan). The antibody reactions were
visualized using diaminobenzidine chromogen and were
counterstained with hematoxylin. Myocarditis severity was
scored on hematoxylin and eosin–stained sections using
grades from 0 to 4: 0, no inﬂammation; 1, >25% of the
heart section involved; 2, 25% to 50%; 3, >50% to 75%; and
4, >75%, as described previously.23 Two independent
researchers scored the slides separately in a blinded
manner.
Assessment of LV Function
The assessment of the LV function was performed in na€ıve
or EAM WT and TNKO mice (14 days after immunization).
The mice were anesthetized with an intraperitoneal injection
of sodium pentobarbital (50 mg/kg). The LV apex was
exposed via a subdiaphragmatic incision. An apical stab was
made with a 27-gauge needle containing a ﬁber pressure
sensor (FPI-LS-PT9; FISO Technologies, Inc, Quebec, Can-
ada),27 placed to span the long axis of the LV. Pressure
measurements were obtained at steady state. All signals
were analyzed with a signal conditioner (FPI-LS-10; FISO
Technologies, Inc) and data acquisition system (LabTrax 4,
World Precision Instruments, Sarasota, FL) and then stored
on disks for off-line analysis using software (LabScribe, iWorx
Systems, Inc, Dover, NH). The following indices were
assessed: heart rate, systolic and end-diastolic LV pressures,
and maximal and minimum rates of LV pressure development
(dP/dt).
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Flow Cytometric Analyses and Intracellular
Cytokine Staining
Heart inﬂammatory cells were isolated and processed as
previously described.5,28 For the ﬂow cytometric analysis of
the surface markers and cytoplasmic cytokines, the cells were
stained directly using ﬂuorochrome-conjugated mouse-spe-
ciﬁc antibodies and analyzed with a FACSCalibur instrument
(BD Biosciences). For the analysis of the intracellular cytokine
production, the cells were stimulated with 50 ng/mL phorbol
12-myristate 13-acetate (Sigma-Aldrich), 750 ng/mL ionomy-
cin (Sigma-Aldrich), and 10 lg/mL brefeldin A (eBioscience)
for 5 hours. The antibodies were purchased from eBioscience
and included CD4, CD45, Forkhead box protein (Foxp)3,
interferon (IFN)-c, and IL-17A.
Stimulation of DCs
BMDCs (59105) generated as described above were
cultured with TN-C (10 lg/mL) for 48 hours. In some
experiments, 0.1 lmol/L TAK242 (Millipore), a selective
TLR4 signal transduction inhibitor, was added. Culture
supernatants were subjected to measurements of cytokine
or chemokine production. For the Western blotting analysis,
we used DCs obtained from spleens of na€ıve WT and TNKO
mice by anti-CD11c microbeads (Miltenyi Biotec). To
evaluate the TLR4 expression or NF-KB signaling, the DCs
were stimulated with TN-C (10 lg/mL) or tumor necrosis
factor-a (20 ng/mL) for 15 minutes and were subjected to
analysis.
In Vitro Th17 Induction
We used a CD4+CD62L+ T-cell isolation kit (Miltenyi Biotec)
and anti-CD11c microbeads (Miltenyi Biotec) to isolate
CD4+ na€ıve T cells and DCs from spleens, respectively. The
CD4+ na€ıve T cells (19106) were co-cultured with DCs
(59104) and stimulated with 10 lg/mL TN-C for 72 hours.
In some experiments, DCs were pretreated with TAK242
(0.1 lmol/L) or anti-IL-6 antibody (10 lg/mL; R&D Sys-
tems). The supernatants were collected and the cytokines
were measured.
Measurements of Cytokines and Chemokines
The hearts were homogenized in media containing 10% fetal
bovine serum. The supernatants were collected after centri-
fugation and stored at 80°C. The concentrations of
cytokines and chemokines in the heart homogenates, serum,
or culture supernatants were measured by the use of
Millipore multiplex immunoassay panels (Millipore). In some
cases, the cytokine levels were conﬁrmed with a Quantikine
ELISA kit (R&D Systems). For measurements of the TN-C
concentration, the hearts were homogenized in a buffer
containing 150 mmol/L NaCl, 25 mmol/L Tris (pH 7.4),
5 mmol/L EDTA, 10 mmol/L sodium pyrophosphate,
10 mmol/L NaF, 1 mmol/L Na3NO4, and complete minipro-
tease inhibitors (Roche). The proteins were extracted from
the homogenized samples by adding Triton X-100 (Sigma) to
a ﬁnal concentration of 1%. Suspensions of hearts mixed with
1% Triton X were vortexed and incubated on ice for 2 hours.
Then, the suspensions were centrifuged at 22 200 g for
15 minutes, and the supernatants were collected. The
concentration of the TN-C was measured by a Tenascin-C
Large (FNIII-B) Assay kit (IBL).
Serum Troponin Determinations
Blood was collected from mice at the time of sacriﬁce, and the
serum levels of cardiac troponin I were measured with an ELISA
kit (Mouse Cardiac Tn-I, Ultra Sensitive; Life Diagnostics).
Western Blot Analysis
The total lysates from WT and TNKO DCs were immunoblotted
and probed with primary antibodies against TLR4, NF-KB, and
phospho-NF-KB (Ser536) (Cell Signaling Technology). Horse-
radish peroxidase–conjugated secondary antibodies (Cell
Signaling Technology) were used to identify the binding sites
of the primary antibody.
RNA Extraction and Quantitative Real-Time
Reverse Transcription Polymerase Chain Reaction
All of the hearts removed for the reverse transcription
polymerase chain reaction were snap frozen and stored at
80°C. For the preparation of the total RNA, the tissue was
homogenized using a bead kit (MagNA Lyser Green Beads;
Roche Diagnostics) according to the manufacturer’s instruc-
tions. The total RNA was extracted using a MagNA Pure
Compact Instrument (Roche Applied Science) together with a
MagNA Pure Compact RNA Isolation Kit (Roche Applied
Science) according to the manufacturer’s instructions. cDNA
was synthesized from 1 lg total RNA with an Omniscript RT
kit (Qiagen). A quantitative-reverse transcription polymerase
chain reaction analysis was performed with the LightCycler
480 system (Roche Applied Science) with a Universal Probe
Library (Roche Applied Science). The primers for the mouse
Tnc were 50-CCCTCTCTCTGTTGAGGTCTTG-30 (sense) and 50-
CCCAGCTGACCTCAGTCAC-30 (antisense). The primers for the
mouse Hprt were 50-TCCTCCTCAGACCGCTTTT-30 (sense) and
50-CCTGGTTCATCATCGCTAATC-30 (antisense). Hprt RNA was
used as an internal control.
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Statistics
All data are expressed as meansSEM. The normality was
tested with the Shapiro–Wilk test. The TN-C mRNA and
protein levels after the myocarditis induction were com-
pared with the baseline levels using an unpaired 2-tailed
t test (Figure 1B). The heart-to-body-weight ratios, serum
troponin I concentrations, ﬂow cytometric analyses data,
hemodynamic parameters, and cytokines/chemokine levels
were compared between 2 groups by an unpaired 2-tailed
t test (Figures 2C through 2H, 3, 4, 5B through 5D, 6, and
8C and 8D). A 1-way analysis of variance was used to
compare the levels of the TN-C in multiple groups
(Figure 5A). To compare the severity scores of myocarditis
between 2 groups, the Mann–Whitney U test was used
(Figures 2B, 8B, and Table). The Fisher Exact test was used
to compare the prevalence of DC-induced myocarditis
between the control group and the other 4 groups,
respectively (Table). A value of P<0.05 was considered to
be statistically signiﬁcant.
Results
Expression of TN-C in the EAM Hearts
First, we examined the expression of TN-C in WTmice with EAM
that was induced by immunization with cardiac myosin. Around
5 to 6 days after the ﬁrst immunization, small clusters of
inﬁltrating inﬂammatory cells appeared, and TN-C became
detectable (Figure 1A). The TN-C expression peaked at day 14,
and themolecule was localized to the interstitial spaces in areas
where inﬂammatory cell inﬁltration was evident (Figure 1A).
The myocardial inﬂammation and TN-C expression gradually
subsided and disappeared around 25 days after immunization
(Figure 1A). A quantitative-reverse transcription polymerase
A B
Figure 1. Tenascin-C (TN-C) expression in cardiac myosin-induced autoimmune myocarditis. BALB/c
mice were immunized twice, on days 0 and 7, with 100 lg of cardiac myosin epitope peptide (MyHC-a).
A, Representative histology of myocarditis on days 5, 14, and 25, respectively. Hematoxylin and eosin
staining (i) and immunostaining for TN-C (ii). Scale bars=50 lm. B, The expression of TN-C in hearts
obtained from immunized mice at the indicated time points. Immunization on days 0 and 7 are indicated
with red arrows. TN-C mRNA expression was evaluated by quantitative reverse transcription–polymerase
chain reaction. The results are reported as the fold change in the gene expression relative to the expression
on day 0. The TN-C protein levels were measured by an ELISA. n=4 per group at each time point. Error bars
represent the meanSEM. *P<0.05 vs day 0. CFA indicates complete Freund’s adjuvant.
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chain reaction analysis and ELISA showed that TN-C was
expressed in parallel with the histological ﬁndings (Figure 1B).
TNKO Mice Are Protected From Progression of
EAM
To determine whether TN-C contributed to the progression
of myocarditis, we compared the severity of myocarditis in
WT and TNKO mice. On day 14 after immunization, when
the TN-C expression had peaked, a histopathological
examination revealed larger areas occupied by heart-inﬁl-
trating cells in the myocardium of WT mice compared with
TNKO mice (Figure 2A). TNKO mice had a signiﬁcantly lower
myocarditis severity score than did the WT mice (Figure 2B).
The heart-to-body-weight ratio in the EAM-TNKO mice had
signiﬁcantly decreased compared with that in the EAM-WT
mice (Figure 2C), as did the level of circulating cardiac
troponin I, a clinical marker of cardiomyocyte damage,29 but
these parameters were comparable between the WT and
TNKO mice at baseline (Figure 2D). A ﬂow cytometric
analysis of the heart inﬁltrates revealed an attenuation of
the inﬂammatory cells (CD45+ leukocytes) in TNKO mice
compared with that in WT mice (Figure 2E). No difference
was found in the percentage of CD4+ T cells among the
CD45+ cells between both groups (Figure 2F). Intracellular
staining of the CD4+ cells revealed that the proportion of IL-
17A+ cells (Th17) was higher and that of Foxp3+ cells
(regulatory T cells) was lower in WT than TNKO mice,
A
E
G H
F
B C D
Figure 2. Tenascin-C (TN-C) deﬁciency inhibits inﬂammation in the heart. Wild-type (WT) and TN-C knockout (TNKO) mice were immunized
with cardiac myosin peptide on days 0 and 7. A, Representative hematoxylin and eosin–stained sections of hearts on day 14 from WT and TNKO
mice. Scale bar=100 lm. B, Severity of myocarditis in the heart sections. C, Heart-to-body-weight ratios (HW/BW) in WT and TNKO mice before
and after experimental autoimmune myocarditis (EAM) induction (day 14). D, Circulating troponin I (TnI) concentration of WT and TNKO mice
before and after EAM induction (day 14). E through G, Inﬂammatory cells inﬁltrating the heart were isolated and analyzed by ﬂow cytometry of
WT and TNKO mice before and after EAM induction (on day 14). E, Absolute number of CD45+ cells, frequency of CD45+ cells within live cells,
and representative plots are shown. F, Absolute number of CD4+ cells, frequency of CD4+ cells within CD45+ cells, and representative plots are
shown. Representative plots (gated on CD4+ T cells) and the frequency of both the interferon (IFN)-c+ (Th1), interleukin (IL)-17+ (Th17), and
Foxp3+ (regulatory T-cell) cells among all CD4+ cells (G) are shown. n=5 to 8 per group (B through G). H, Splenocytes in na€ıve WT and TNKO mice
were isolated and analyzed by a ﬂow cytometric analysis. Representative plots (gated on CD4+ T cells) and the frequency of the IFN-c+ (Th1), IL-
17+ (Th17), and Foxp3+ cells among all CD4+ cells is shown. n=4 per group. The bar graphs show the group meanSEM. The results of 1 of 2
representative experiments are shown. *P<0.01, **P<0.05. Foxp indicates Forkhead box protein; ND, not detected; SSC, side scatter.
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whereas the proportion of IFN-c+ cells (Th1) was similar
between WT and TNKO mice (Figure 2G). The CD4+ T-cell
proportions in splenocytes at day 0 did not differ between
WT and TNKO mice (Figure 2H), indicating that the
deﬁciency of TN-C did not inﬂuence CD4+ T-cell differenti-
ation in the non-EAM condition. To further evaluate the
effects of TN-C deﬁciency on the severity of EAM, we
examined hemodynamic parameters using a pressure sen-
sor. In the na€ıve mice, there was no statistical difference in
the heart rate, LV systolic pressure, LV end-diastolic
pressure, or dP/dt between the WT and TNKO mice
(Figure 3A through 3E). The LV end-diastolic pressure
increased and dP/dt decreased more in the WT EAM
mice than in the WT na€ıve mice, consistent with severe
myocarditis (Figure 3B through 3E). In comparison, TNKO
mice showed no signiﬁcant deterioration in these parame-
ters even after the induction of EAM (Figure 3B through 3E).
Taken together, the presence of TN-C in the heart during
the acute phase of EAM might contribute to the inﬁltration
of inﬂammatory cells including Th17 into the heart and to
the progression of myocarditis and LV dysfunction.
TN-C Promotes Proinﬂammatory Cytokine and
Chemokine Synthesis in the Heart
To gain new insights into the mechanism of protection against
myocarditis in TNKO mice, we examined whether a TN-C
deﬁciency affected the cytokine and chemokine milieu in the
heart. In naive WT and TNKO hearts, the expression of
proinﬂammatory cytokines and chemokines was quite small
to none (Figure 4). On day 14 following immunization, the
heart homogenates from TNKO mice had signiﬁcantly reduced
levels of the proinﬂammatory cytokines IL-1a, IL-1b, IL-6, IL-
17, tumor necrosis factor-a, and transforming growth factor-b
Table. Prevalence and Severity of MyHC-a-Loaded DC-Induced Myocarditis in WT and TN-C KO Mice
Donors Recipients Activation Prevalence (Day 10) Median Severity Grade at Day 10 (Individual Data)
WT WT PBS 0/7 0
WT WT LPS 7/7* 2 (2, 2, 2, 2, 3, 3, 3)†
WT WT TN-C 7/7* 2 (1, 2, 2, 2, 3, 3, 3)†
TNKO TNKO PBS 0/7 0
TNKO TNKO TN-C 7/7* 2 (1, 1, 2, 2, 2, 3, 3)†
DC indicates dendritic cell; LPS, lipopolysaccharide; MyHC-a, a-myosin H-chain peptide; TN-C, tenascin-C; TNKO, TN-C knockout; WT, wild-type.
*P<0.001 (Fisher’s exact test), †P<0.01 (Mann-Whitney U test) vs WT-DCs (with PBS)-induced myocarditis.
A
D E
B C
Figure 3. Effects of tenascin-C (TN-C) deﬁciency on the hemodynamic parameters in experimental
autoimmune myocarditis (EAM) mice. A, Heart rate; (B) Left ventricular (LV) systolic pressure (LVSP); (C) LV
end-diastolic pressure (LVEDP); (D) Maximal rate of the increase in the LV pressure (+dP/dt); and (E), Maximal
rate of the decrease in the LV pressure (dP/dt). Na€ıve or EAM wild-type (WT) and TN-C knockout (TNKO)
mice (day 14) were analyzed. n=5 to 7 per group. Bar graphs show the group meanSEM. *P<0.05.
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(Figure 4). Also, the lack of TN-C had signiﬁcantly reduced the
levels of the following chemokines: macrophage inﬂammatory
protein (MIP)-1a (CCL3), MIP-1b (CCL4), MIP-2 (CXCL2),
monocyte chemoattractant protein-1 (MCP-1), keratinocyte
chemoattractant (KC) (CXCL1), and IFN-c-induced protein
(IP)-10 (CXCL10) (Figure 4). Thus, protection from autoim-
mune myocarditis in TNKO mice is associated with abrogation
of proinﬂammatory molecules and chemokines in the heart.
TN-C Mediates DC Activation and Th17 Cell
Development
EAM is a CD4+ T-cell-mediated disease,3,4 and DCs are the
major antigen-presenting cells (and key players in the priming
of appropriate CD4+ T-cell responses. To assess whether TN-C
is secreted by DCs, we generated BMDCs in vitro by culturing
bone marrow cells obtained from WT mice with granulocyte/
macrophage colony-stimulating factor. We found that BMDCs
activated with LPS produced only a small amount of TN-C, as
did nonstimulated BMDCs (Figure 5A). Therefore, we cultured
WT BMDCs in the presence of TN-C and investigated the
effects of TN-C on BMDCs in proinﬂammatory cytokine and
chemokine production. When BMDCs were stimulated with
TN-C, they produced greater amounts of the proinﬂammatory
cytokines IL-1a, IL-1b, IL-6, IL-12p40, and IFN-c than did
those without TN-C (Figure 5B). TN-C stimulation also
promoted BMDCs to produce the chemokines MCP-1, MIP-
1a, MIP-1b, MIP-2, IP-10, regulated upon activation, normal
T-cell expressed and secreted (RANTES), and KC and growth
factors G-CSF and granulocyte/macrophage colony-stimulat-
ing factor (Figure 5B). These data indicated that TN-C
promotes the production of many types of chemokines and
inﬂammatory cytokines from DCs, which participate in the
proliferation, accumulation, and activation of immune cells
such as monocytes, macrophages, and lymphocytes. More-
over, TN-C induced the production of IL-6, a key cytokine in
Th17 development,30 by BMDCs in a dose-dependent manner
(Figure 5C). On the basis of this signiﬁcant effect of TN-C on
IL-6 secretion by DCs, we next attempted to conﬁrm that TN-
C-stimulated BMDCs induce Th17 development. We cocul-
tured TN-C-stimulated DCs and na€ıve CD4+ T cells in the
presence of anti-CD3 monoclonal antibody and transforming
growth factor-b and analyzed IL-17 production in the culture
supernatant. As expected, we found that TN-C-stimulated DCs
promoted IL-17 production from CD4+ T cells (Figure 5D).
Moreover, we conﬁrmed the neutralization of IL-6 by using a
speciﬁc antibody that inhibited the effects of TN-C-stimulated
DCs on the promotion of IL-17 production from CD4+ T cells
(Figure 5D). These results indicated that TN-C encouraged the
generation of Th17 via the secretion of IL-6 from DCs.
TN-C Activates DCs via TLR4
Multiple cell-surface receptors are known to bind to the TN-C
molecule.31 Among them, TLR4 has been shown to be a
receptor that transmits important signals to modulate
inﬂammatory response.13 To determine whether TN-C acti-
vates DCs via TLR4, we developed BMDCs from TLR4KO mice
(TLR4KO-BMDC) and examined whether TN-C induced the
cytokine and chemokine secretion. TLR4KO-BMDCs failed to
produce the proinﬂammatory cytokines IL-1a, IL-1b, IL-6,
IL-12p40, and IFN-c even under stimulation with adequate
Figure 4. Tenascin-C (TN-C) deﬁciency affected the cytokine milieu in the heart. Cytokine and chemokine secretion in homogenized hearts
obtained from na€ıve and experimental autoimmune myocarditis (EAM) (on day 14) wild-type (WT) and TN-C knockout (TNKO) mice was assessed
by an ELISA. n=4 to 5 per group. The bar graphs show the group meanSEM. The results of 1 of 2 representative experiments are shown.
*P<0.05, **P<0.01. IL indicates interleukin; IP, IFN-c-induced protein; KC, keratinocyte chemoattractant; MCP, monocyte chemoattractant
protein; MIP, macrophage inﬂammatory protein; ND, not detected; RANTES, regulated on activation, normal T-cell expressed and secreted; TGF,
transforming growth factor; TNF, tumor necrosis factor.
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amounts of TN-C (Figure 6A). TN-C did not increase the
chemokine production, including that of MIP-1a, MIP-1b, MIP-
2, RANTES, KC, and IP-10 from TLR4KO-BMDCs (Figure 6A).
Furthermore, TLR4 inhibitor TAK242 attenuated TN-C-induced
production of IL-1a, IL-1b, IL-6, IL-12p40, IFN-c, MIP-1a,
MIP-1b, MIP-2, RANTES, KC, and IP-10 (Figure 6B). These
data indicated that TN-C-activated DCs produce proinﬂam-
matory cytokine/chemokine mainly via a TLR4-mediated
signaling cascade. Next, we cocultured na€ıve CD4+ T cells
and TN-C-stimulated TLR4KO-BMDCs. Despite the presence
of a sufﬁcient amount of TN-C, the IL-17 secretion from CD4+
T cells did not increase (Figure 6C). Furthermore, we
cocultured na€ıve CD4+ T cells and TN-C-stimulated DCs from
WT mice with or without TAK242. Pretreatment with TAK242
also resulted in an attenuation of the IL-17 secretion from
CD4+ T cells (Figure 6D). Collectively, DCs activated by the
TLR4-mediated signaling mainly contributed to the activation
of DCs by TN-C, which promoted Th17 differentiation.
TN-C-Stimulated DCs Gain a Myocarditis-Inducing
Capacity via TLR4
To collect direct evidence that TN-C provides DCs with the
ability to induce autoimmune myocarditis, we used another
A
C
D
B
Figure 5. Tenascin-C (TN-C) stimulated production of proinﬂammatory cytokines and chemokines by bone marrow (BM)–derived dendritic
cells (DCs) and differentiated na€ıve CD4+ cells into Th17 cells. A, DCs generated from BM (BMDCs) were cultured in the presence or absence of
lipopolysaccharide (LPS) 1 lg/mL for 72 hours. TN-C secretions from BMDCs and the TN-C concentration in the medium were measured by an
ELISA. B, BMDCs were cultured in the presence of 10 lg/mL of TN-C for 48 hours, and the supernatants were subjected to multiplex
immunoassay panels for the production of proinﬂammatory cytokines, chemokines, and growth factors. C, BMDCs were cultured in the presence
of the indicated dose of TN-C for 48 hours. TN-C-dose-dependent IL-6 secretions from BMDCs were measured by an ELISA. D, CD62high na€ıve
CD4+ T cells were cultured with DCs, which were obtained from the spleen, in the presence of anti-CD3 mAb (1 lg/mL), TGF-b (2 ng/mL), and
TN-C (10 lg/mL) for 72 hours. In some wells, anti-IL-6 Ab (10 lg/mL) was added. The secretion of IL-17 in the supernatants was analyzed by
an ELISA. The values are expressed as meansSEM of triplicate culture wells. The results of 1 of 2 representative experiments are shown.
*P<0.05, **P<0.01 (compared to no TN-C stimulation). GM-CSF indicates granulocyte/macrophage colony-stimulating factor; IFN, interferon;
IL, interleukin; IP, IFN-c-induced protein; KC, keratinocyte chemoattractant; MCP, monocyte chemoattractant protein; MIP, macrophage
inﬂammatory protein; NS, not signiﬁcant; RANTES, regulated on activation, normal T-cell expressed and secreted; TGF, transforming growth
factor; TNF, tumor necrosis factor.
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AB
C D
Figure 6. Blocking of toll-like receptor (TLR) 4-mediated tenascin-C (TN-C) signaling reduced the IL-6 secretion and Th17 generation. A, Bone
marrow-derived dendritic cells (BMDCs) generated from TLR4 knockout mice were cultured in the presence of 10 lg/mL of TN-C for 48 hours. The
supernatants were subjected to an ELISA analysis for the production of proinﬂammatory cytokines and chemokines. B, BMDCs generated from
wild-type mice were cultured in the presence of 10 lg/mL of TN-C for 48 hours. In some wells, TLR4 inhibitor TAK242 (0.1 lmol/L) was added.
The supernatants were subjected to an ELISA analysis for the production of proinﬂammatory cytokines and chemokines. C, CD62high na€ıve CD4+ T
cells were cocultured with BMDCs generated from TLR4 knockout mice in the presence of anti-CD3 mAb (1 lg/mL), TGF-b (2 ng/mL), and full
TN-C (10 lg/mL) for 72 hours. The secretion of IL-17 in the supernatants was analyzed by an ELISA. D, CD62high na€ıve CD4+ T cells were
co-cultured with DCs, which were obtained from the spleen, in the presence of anti-CD3 mAb (1 lg/mL), TGF-b (2 ng/mL), and TN-C (10 lg/mL)
for 72 hours. In some wells, TLR4 inhibitor TAK242 (0.1 lmol/L) was added. The secretion of IL-17 in the supernatants was analyzed by an ELISA.
The values are expressed as meansSEM of triplicate culture wells. The results of 1 of 2 representative experiments are shown. *P<0.05,
**P<0.01. IFN indicates interferon; IL, interleukin; IP, IFN-c-induced protein; KC, keratinocyte chemoattractant; MIP, macrophage inﬂammatory
protein; NS, not signiﬁcant; RANTES, regulated on activation, normal T-cell expressed and secreted; TGF, transforming growth factor.
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myocarditis model induced by the transfer of cardiac myosin
peptide-loaded BMDCs. In this model, DC-mediated autoim-
mune myocarditis only occurs when DCs are activated
through Toll-like receptors,5 and it is a useful model to
dissect the role of TN-C in the promotion of disease-inducing
DCs. Injection of nonstimulated immature DCs did not
absolutely generate EAM, whereas injection of TN-C-stimu-
lated WT DCs, and LPS-stimulated DCs induced signiﬁcant
myocarditis at a high prevalence (Table). In addition, nonac-
tivated TNKO-BMDCs could not induce EAM, but exogenous
TN-C stimulation of TNKO-BMDCs recovered their ability to
induce EAM (Table).
To determine whether TLR4 expression differed between
WT and TNKO DCs, we analyzed DCs obtained from the spleen
of na€ıve WT and TNKO mice. In the Western blot analysis,
TNKO DCs showed a level of TLR4 expression comparable to
that for WT DCs at baseline or in response to TN-C stimulation
(Figure 7A). MyD88 and IRAK-1 play crucial roles as adaptor
molecules in the signal transduction of TLR4, and the
expression of these proteins leads to the activation of NF-
jB.32 To evaluate whether this signaling was altered in the
TNKO mice, we examined the difference of NF-jB activation in
response to TN-C or tumor necrosis factor-a stimulation
between WT and TNKO DCs. TNKO DCs showed no defect in
the phosphorylation of NF-jBp65, a major component of NF-
jB at serine 536, in response to TN-C or tumor necrosis
factor-a stimulation in comparison to WT DCs (Figure 7B).
These data conﬁrmed that the protection of TNKO mice from
myocarditis did not depend on their insufﬁcient TLR4- or NF-
jB-signaling pathways.
As described above, TLR4-mediated signaling mainly
contributed to the activation of DCs by TN-C. Therefore, to
directly evaluate the role of the TN-C-TLR4 pathway in DCs on
disease induction, we stimulated MyHC-a-loaded-BMDCs
generated from TLR4KO mice with TN-C and transferred
them into recipient mice. As expected, TN-C-stimulated
BMDCs from TLR4KO mice failed to induce myocarditis into
the recipients (Figure 8A and 8B) with a decreased heart-to-
body weight ratio (Figure 8C) and IL-6 production in the heart.
(Figure 8D). These results indicated that TN-C activates DCs
through TLR4 and exacerbates myocarditis.
Discussion
In the cardiovascular system, TN-C is expressed during
embryonic development and plays important roles with regard
to the differentiation of cardiomyocytes and angiogenesis.7,17
TN-C is sparsely detected in normal adults but is upregulated
under pathological conditions accompanying tissue injury and
inﬂammation.7,17 Because of its speciﬁc expression style,
TN-C has been used to date as a biomarker33 or a target for
nuclear imaging in the diagnosis20 of myocarditis. With this
study, we clearly demonstrated the proinﬂammatory role of
TN-C in the initiation of autoimmune myocarditis. To gain new
insights into the immunological inﬂuence of TN-C on
autoimmune myocarditis, we used models of EAM induced
in 2 different ways. The ﬁrst experiment, using MyHC-a/
complete Freund’s adjuvant immunization-induced EAM,
revealed that the presence of TN-C accelerated myocardial
inﬂammation in vivo. The second experiment, using myosin-
speciﬁc DC-mediated EAM, provided direct evidence that TN-
C is essential for DCs to acquire a sufﬁcient ability to induce
autoimmune myocarditis.
DCs are professional antigen-presenting cells and key
players in the priming of appropriate antigen-speciﬁc T-cell
responses against foreign antigens or sometimes self-tis-
sue.6,34 We directly revealed that TN-C aggravates inﬂamma-
tion through interaction with DCs in EAM, and this ﬁnding was
similar to that of a previous experiment using an arthritis
model.12 One of the important functions of DCs during
inﬂammation is the production of various pro-inﬂammatory
cytokines.6 Actually, we found that TN-C-stimulated DCs
promoted more production of proinﬂammatory cytokines than
nonstimulated DCs did (Figure 5B), which was similar to
previous studies that investigated the effects of TN-C or other
extracellular matrix proteins (e.g., osteopontin and galectin-1)
on DCs.12,35–39 Our in vivo study also showed that larger
amounts of the pro-inﬂammatory cytokines IL-1a, IL-1b, and
IL-6 were contained in the heart homogenates of EAM WT
mice than in EAM TNKO mice (Figure 4). As a result, TNKO
mice showed less MyHC-a/complete Freund’s adjuvant–
induced myocarditis and stable hemodynamic parameters
compared to WT mice (Figures 2 and 3). Taken together, TN-C
contributed to the progression of EAM through the production
of the cytokines IL-1, IL-6, and IL-12p40, which are critically
necessary in the pathogenesis of autoimmune heart dis-
ease.40–42 As with the cytokines, TN-C also accelerated the
production of chemokines including MCP-1, MIP-1a, MIP-1b,
A B
Figure 7. Tenascin-C (TN-C) deﬁciency does not affect Toll-like
receptor (TLR) 4 expression and NF-KB signaling. A, Western blot
of TLR4 expression in na€ıve wild-type (WT) and TN-C knockout
(TNKO) DCs left untreated or 15 minutes after stimulation with
TN-C (10 lg/mL). B, Western blot of phosphorylation of NF-KB
p65 at Ser 536 and NF-KB p65 in na€ıve WT and TNKO DCs
15 minutes after stimulation with TN-C (10 lg/mL) or TNF-a
(20 ng/mL). DCs indicates dendritic cells; TNF, tumor necrosis
factor.
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MIP-2, RANTES, KC, and IP-10 by DCs (Figure 5B), and they
were also increased more in the hearts of WT EAM mice
compared to TNKO EAM mice (Figure 4). In previous exper-
imental myocarditis studies, each of MCP-1,43 MIP-1a,43 MIP-
1b,44 MIP-2,45 RANTES,44 KC,46 and IP-1047 has been
identiﬁed as a chemotactic factor effecting the inﬁltration of
various inﬂammatory cells into inﬂamed tissue. At the site of
injury and inﬂammation, TN-C can provide a scaffold for
immune cell adhesion and migration.10 In fact, our ﬂow
cytometric analysis of inﬁltrating cells into inﬂamed WT hearts
revealed that peak TN-C expression was associated with an
increase in inﬁltrating leukocytes at around 14 days after the
ﬁrst immunization (Figures 1 and 2E through 2G).
We also revealed that TN-C was important for myosin-
loaded DCs to acquire the ability to induce EAM. This DC-
mediated myocarditis has been established as a model of
EAM progression into DCM and heart failure even after
resolution of acute inﬂammatory inﬁltrates.5 Consistent with a
previous report, our results showed that LPS-stimulated DCs
generated signiﬁcant myocarditis, whereas nonactivated DCs
did not (Table).5 We also showed that stimulation of DCs with
TN-C instead of LPS successfully induced EAM at a high
prevalence similar to that with LPS stimulation (Table). DC-
mediated autoimmunity and heart disease occur only when
DCs are activated through Toll-like receptors.5 Thus, these
results suggest that TN-C has an ability comparable to that of
LPS for providing DCs with the capacity to induce myocarditis
via TLR4 activation. Furthermore, immature BMDCs from
TNKO mice did not initiate myocarditis in recipient TNKO
mice, but the presence of exogenous TN-C provided TNKO-
BMDCs with the full ability to induce EAM (Table). This
indicated that the presence of exogenous TN-C is important
for acquiring DC activation to induce myocarditis. In clinical
settings, myocardial tissues obtained from DCM patients
sometimes show active myocarditis without evidence of an
active viral invasion into their hearts.48 Taken together, it is
possible that continuous activation of DCs is inducible by
extracellular environments regulated in the presence of
inﬂammation even after the active infection and microbe
elements in the inﬂamed heart are diminished.
We showed that activated BMDCs synthesized TN-C at a
very low level (Figure 5A), although other published data
demonstrated that DCs obtained from peripheral blood or
immunized draining lymph nodes can produce TN-C.12,49
A
B
(i) (ii)
C D
Figure 8. Transfer of myosin-speciﬁc bone marrow–derived dendritic cells (BMDCs) generated from Toll-
like receptor 4 knockout (TLR4-KO) mice reduced the myocardial inﬂammation. BMDCs generated from
wild-type (WT) or TLR4KO mice were pulsed overnight with 10 lg/mL MyHC-a peptide and stimulated for
another 4 hours with 10 lg/mL TN-C and 5 lg/mL anti-CD40L. Recipient mice received 59105 pulsed
and activated WT-BMDCs or TLR4KO-BMDCs i.p. on days 0, 2, and 4 and were killed 10 days after the ﬁrst
injection. A, Representative histology (hematoxylin and eosin staining) of the myocarditis on day 10 after
the DC transfer. Left image, WT-BMDCs transferred myocarditis, right image, TLR4KO-BMDCs transferred
myocarditis. Scale bars=100 lm. B, Severity of myocarditis on day 10 after DC transfer. C, Heart-to-body-
weight ratios (HW/BW) on day 10 after DC transfer. D, IL-6 secretion in the homogenized hearts 10 days
after BMDC transfer was assessed by an ELISA. The bar graphs show the group meanSEM. n=7 per group.
*P<0.01. IL indicates interleukin; MyHC, myosin H-chain peptide; ND, not detected; TN-C, tenascin-C.
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The differences in the maturation and activation between
artiﬁcially generated BMDCs and in vivo–derived DCs might
have affected the production of TN-C. In the inﬂamed heart,
interstitial ﬁbroblasts at the site of injury are the major source
of TN-C.26,50 TN-C molecules secreted by interstitial cells in
the extracellular spaces could modulate immune cell activity
in a paracrine fashion.
TN-C inﬂuenced the generation of Th17 cells inﬁltrating
into inﬂamed heart (Figure 2G). Moreover, na€ıve CD4+ T cells
cocultured with TN-C-activated DCs were more differentiated
into Th17 cells than were those without TN-C stimulation
(Figure 5D). Recently, a subset of IL-17-producing Th17 cells
has been described and shown to have a crucial role in the
induction of autoimmune tissue injury.1 Actually, EAM is
worsened by the transplantation of Th17 cells, and treatment
by IL-17-blocking antibody or active vaccination against IL-17
attenuates the severity of EAM.28,51 We also found that the
frequency of Foxp3+ regulatory T cells was reduced more in
the myocardium of WT mice than TNKO mice (Figure 2G).
Foxp3+ regulatory T cells inhibit autoimmunity and protect
against tissue injury.52 The current consensus is that IL-6
induces Th17 differentiation together with transforming
growth factor-b30 and is essential for the initiation of EAM
through Th17 differentiation.53,54 Conversely, transforming
growth factor-b-mediated conversion of na€ıve CD4+ cells into
Foxp3+ regulatory T cells is strongly inhibited by IL-6.30 In
vitro, TN-C-stimulated DCs produced a high amount of IL-6
(Figure 5B and 5C), and then a blockade of IL-6 inhibits the
TN-C-mediated Th17 polarization (Figure 5D). Taken together,
TN-C inﬂuences the generation of pathogenic Th17 cells
through its ability to promote IL-6 synthesis from DCs and
forms an important link from innate to adaptive immunity.
Moreover, IL-1 and granulocyte/macrophage colony-stimulat-
ing factor are known as factors promoting the generation and
maintenance of Th17 cells.55,56 Our results indicating that TN-
C promoted IL-1 and granulocyte/macrophage colony-stimu-
lating factor production by DCs (Figure 5B) might also explain
the Th17 expansion in WT mice. Consistent with our data,
there is evidence that TN-C plays a role in promoting T-cell
activation14 and polarization.12,57
Finally, we conﬁrmed that the interaction of TN-C and
DCs depended on TLR4-mediated signaling. Originally, TLR4
was shown to play a critical role in the recognition of LPS
and subsequent signal transduction.32 However, recent
Figure 9. Schematic illustration showing how tenascin-C (TN-C)-stimulated dendritic cells (DCs) induce
myocarditis. TN-C aggravates myocardial inﬂammation by stimulation of myosin-loaded DCs via Toll-like
receptor (TLR)-4-mediated signaling. DCs stimulated by TN-C produce cytokines and growth factors (IL-6, IL-
1, and GM-CSF) that contribute to the generation of cardiac myosin epitope peptide (MyHC)-a-speciﬁc Th17
cells. Chemokines secreted by TN-C-stimulated DCs help to accumulate inﬂammatory cells into the
inﬂamed heart. GM-CSF indicates granulocyte/macrophage colony-stimulating factor; IL, interleukin; IP,
IFN-c-induced protein; KC, keratinocyte chemoattractant; MHC, major histocompatibility complex; MIP,
macrophage inﬂammatory protein; RANTES, regulated on activation, normal T-cell expressed and secreted;
TCR, T-cell receptor.
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studies have indicated that TLR4 also plays a critical role in
inﬂammatory responses to endogenous triggers.58 Moreover,
it was reported that self-antigen-loaded DCs activated via
TLR4 stimulation by endogenous ligands generated by tissue
damage is sufﬁcient for the initiation of an autoimmune
response in genetically susceptible individuals.59 Thus, the
TLR4 signaling pathway is an important mediator of autoim-
mune reactions that cause inﬂammation-induced injury in the
myocardium. In the present study, the lack of TLR4-mediated
signaling canceled the effects of TN-C on DCs to produce
cytokines or chemokines and IL-17 secretion from Th17 cells
(Figure 6). TLR4 signaling is composed of 2 distinct
pathways. One is a MyD88-dependent pathway that is
critical to the induction of inﬂammatory cytokines including
IL-1b, IL-6, and IL-12p40.32,60 The other is a Toll/IL-1R
domain-containing adapter inducing IFN-b (TRIF)-dependent
pathway that regulates the enhancement of DC maturation
and induction of IP-10.32,60 TAK242, a selective TLR4 signal
transduction inhibitor, interferes with the interaction
between TLR4 and the adaptor molecules of both path-
ways.61 Therefore, TAK242 could reduce IL-1b, IL-6, IL-
12p40, and IP-10 secretion from DCs at the same level of
TLR4 deﬁciency generated by the inhibition of both the
MyD88- and TRIF-dependent pathways (Figure 6A and 6B).
Regarding the concern that a deﬁciency of TLR4 and its
downstream signaling in TNKO mice may have an effect on
the protection from myocarditis, we found no differences in
TLR4 expression and NF-KB activation between WT and TNKO
mice (Figure 7). Lastly, we conﬁrmed that a TLR4 deﬁciency
canceled the effect of TN-C in promoting DC-mediated
myocarditis and attenuated the inﬂammation in vivo (Fig-
ure 8). This result provides direct evidence that blocking
the TLR4-mediated pathway is effective in inhibiting TN-C-
mediated myocardial inﬂammation.
A growing body of evidence suggests that TN-C is highly
expressed in various inﬂammatory lesions of the heart, such
as the Coxsackie virus B3–induced viral myocarditis model,
another mouse model of myocarditis,62,63 or the angiotensin
II–induced hypertensive inﬂammation/ﬁbrosis heart
model,19,64 and it may modulate the immune system during
tissue remodeling. Indeed, deletion of TN-C reduces ventric-
ular remodeling after myocardial infarction, suggesting that
TN-C may play an important role in the pathology of
remodeling by modulating inﬂammation.65
In conclusion, TN-C plays crucial roles in Th17 differenti-
ation through the induction of IL-6 from DCs as a critical
event for the initiation of EAM. Our proposed mechanism of a
TN-C-mediated progression of myocardial inﬂammation is
illustrated in Figure 9. Our data provide the ﬁrst evidence that
TN-C activation of DCs via the common receptor, TLR4, is
critical for the expansion of EAM and provides new insight into
a possible therapeutic target for autoimmune myocarditis.
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